Hemispherx Biopharma Announces First Patient Treated in Phase 2 Ovarian Cancer Clinical Trial Evaluating Ampligen in Combination with Pembrolizumab and Cisplatin

World News: . []

OCALA Fla June 12 2019 GLOBE NEWSWIRE -- NYSE American HEB Hemispherx LINK  Inc announced today that the first patient has been LINK  in the Phase 2 recurrent ovarian LINK  program at the University of Pittsburgh Medical Cente r (UPMC...

More news and information about Hemispherx Biopharma, Inc.

Published By:

Globe Newswire: 20:31 GMT Wednesday 12th June 2019

Published: .

Search for other references to "hemispherx" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us